Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions

被引:4
|
作者
Kang, Gyeong Hoon [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea
关键词
ISLAND METHYLATOR PHENOTYPE; POPULATION-BASED SAMPLE; SPORADIC COLON-CANCER; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; SERRATED POLYPS; LYNCH SYNDROME; CLINICOPATHOLOGICAL FEATURES; CPG-ISLANDS; MUTATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-In addition to chromosomal instability and microsatellite instability (MSI), a third pathway, epigenetic instability, has been implicated in progression to colorectal carcinogenesis. CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that occur through the epigenetic instability pathway and that are characterized by widespread hypermethylation of promoter CpG island loci, resulting in the inactivation of several tumor suppressor genes or tumor-related genes. Colorectal cancers can be classified into 4 molecular subtypes according to their CIMP and MSI statuses: CIMP+/MSI+, CIMP+/MSI-, CIMP-/MSI+, and CIMP-/MSI-. There are differences between Western (United States and European Union) and Eastern (Korea and China) populations in the number of CRCs that are MSI+, and in the number of MSI+ CRCs that are CIMP+. Objective.-To review the clinicopathologic and molecular features of the 4 molecular subtypes of CRCs and their precursor lesions, and to emphasize geographic differences in CRCs between Eastern and Western populations. Data Sources.-This article is based on the author's own experimental data and a literature review of relevant articles indexed in PubMed (US National Library of Medicine). Conclusion.-The 4 molecular subtypes of CRC that are defined by their CIMP and MSI statuses are characterized by their own distinct clinicopathologic and molecular features and precursor lesions. In particular, the clinicopathologic features of MSI+ CRCs differ depending on the CIMP status. Further understanding of the heterogeneity in CRC molecular pathways may help to explain the diverse morphologic features of CRCs. (Arch Pathol Lab Med. 2011;135:698-703)
引用
收藏
页码:698 / 703
页数:6
相关论文
共 50 条
  • [41] MmCMS: mouse models' consensus molecular subtypes of colorectal cancer
    Amirkhah, Raheleh
    Gilroy, Kathryn
    Malla, Sudhir B. B.
    Lannagan, Tamsin R. M.
    Byrne, Ryan M. M.
    Fisher, Natalie C. C.
    Corry, Shania M. M.
    Mohamed, Noha-Ehssan
    Naderi-Meshkin, Hojjat
    Mills, Megan L. L.
    Campbell, Andrew D. D.
    Ridgway, Rachel A. A.
    Ahmaderaghi, Baharak
    Murray, Richard
    Llergo, Antoni Berenguer
    Sanz-Pamplona, Rebeca
    Villanueva, Alberto
    Batlle, Eduard
    Salazar, Ramon
    Lawler, Mark
    Sansom, Owen J. J.
    Dunne, Philip D. D.
    BRITISH JOURNAL OF CANCER, 2023, 128 (07) : 1333 - 1343
  • [42] Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
    Phipps, Amanda I.
    Limburg, Paul J.
    Baron, John A.
    Burnett-Hartman, Andrea N.
    Weisenberger, Daniel J.
    Laird, Peter W.
    Sinicrope, Frank A.
    Rosty, Christophe
    Buchanan, Daniel D.
    Potter, John D.
    Newcomb, Polly A.
    GASTROENTEROLOGY, 2015, 148 (01) : 77 - U498
  • [43] The potential role of platelets in the consensus molecular subtypes of colorectal cancer
    Michael Lam
    Jason Roszik
    Preeti Kanikarla-Marie
    Jennifer S. Davis
    Jeffrey Morris
    Scott Kopetz
    David G. Menter
    Cancer and Metastasis Reviews, 2017, 36 : 273 - 288
  • [44] MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
    Raheleh Amirkhah
    Kathryn Gilroy
    Sudhir B. Malla
    Tamsin R. M. Lannagan
    Ryan M. Byrne
    Natalie C. Fisher
    Shania M. Corry
    Noha-Ehssan Mohamed
    Hojjat Naderi-Meshkin
    Megan L. Mills
    Andrew D. Campbell
    Rachel A. Ridgway
    Baharak Ahmaderaghi
    Richard Murray
    Antoni Berenguer Llergo
    Rebeca Sanz-Pamplona
    Alberto Villanueva
    Eduard Batlle
    Ramon Salazar
    Mark Lawler
    Owen J. Sansom
    Philip D. Dunne
    British Journal of Cancer, 2023, 128 : 1333 - 1343
  • [45] Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
    Dienstmann, Rodrigo
    Vermeulen, Louis
    Guinney, Justin
    Kopetz, Scott
    Tejpar, Sabine
    Tabernero, Josep
    NATURE REVIEWS CANCER, 2017, 17 (04)
  • [46] Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer
    Gherman, Alexandra
    Bolundut, Dinu
    Ecea, Radu
    Balacescu, Loredana
    Curcean, Sebastian
    Dina, Constantin
    Balacescu, Ovidiu
    Cainap, Calin
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [47] Reconciliation of classification systems defining molecular subtypes of colorectal cancer
    Sadanandam, Anguraj
    Wang, Xin
    de Sousa E Melo, Felipe
    Gray, Joe W.
    Vermeulen, Louis
    Hanahan, Douglas
    Medema, Jan Paul
    CELL CYCLE, 2014, 13 (03) : 353 - 357
  • [48] Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
    Dienstmann, Rodrigo
    Vermeulen, Louis
    Guinney, Justin
    Kopetz, Scott
    Tejpar, Sabine
    Tabernero, Josep
    NATURE REVIEWS CANCER, 2017, 17 (02) : 79 - 92
  • [49] Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
    Coebergh van den Braak, R. R. J.
    ten Hoorn, S.
    Sieuwerts, A. M.
    Tuynman, J. B.
    Smid, M.
    Wilting, S. M.
    Martens, J. W. M.
    Punt, C. J. A.
    Foekens, J. A.
    Medema, J. P.
    IJzermans, J. N. M.
    Vermeulen, L.
    BMC CANCER, 2020, 20 (01)
  • [50] Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
    R. R. J. Coebergh van den Braak
    S. ten Hoorn
    A. M. Sieuwerts
    J. B. Tuynman
    M. Smid
    S. M. Wilting
    J. W. M. Martens
    C. J. A. Punt
    J. A. Foekens
    J. P. Medema
    J. N. M. IJzermans
    L. Vermeulen
    BMC Cancer, 20